Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merrick I Ross

Showing results (231-240 of 286) with videos related to

Pageof 29
Sort By:
Annals of Surgical Oncology|May 26, 2026
The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Annals of Surgical Oncology|June 1, 2026
ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Cancer|January 11, 2005
Breast conservation after neoadjuvant chemotherapyAllen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanomaCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.
Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.
Pageof 29

Showing results (231-240 of 286) with videos related to

Sort By:
Pageof 29
Annals of Surgical Oncology|May 26, 2026
The Role of Adjuvant Primary Site Radiotherapy for Cutaneous Melanoma Patients with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2011
Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapyRichard W Joseph, Vijay R Peddareddigari, Ping Liu, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Final Results of the Sunbelt Melanoma Trial: A Multi-Institutional Prospective Randomized Phase III Study Evaluating the Role of Adjuvant High-Dose Interferon Alfa-2b and Completion Lymph Node Dissection for Patients Staged by Sentinel Lymph Node BiopsyKelly M McMasters, Michael E Egger, Michael J Edwards, et al.
Annals of Surgical Oncology|June 1, 2026
ASO Visual Abstract: The Role of Adjuvant Primary Site Radiotherapy for Patients with Cutaneous Melanoma with MicrosatellitosisAnjali Devireddy, Yifan Yi, Kelsey N Nordlund, et al.
Cancer|January 11, 2005
Breast conservation after neoadjuvant chemotherapyAllen M Chen, Funda Meric-Bernstam, Kelly K Hunt, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2006
Prospective multi-institutional study of reverse transcriptase polymerase chain reaction for molecular staging of melanomaCharles R Scoggins, Merrick I Ross, Douglas S Reintgen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2020
Circulating Tumor Cells and Early Relapse in Node-positive MelanomaAnthony Lucci, Carolyn S Hall, Sapna P Patel, et al.
Oncoimmunology|August 15, 2025
Lymphodepletion, tumor-infiltrating lymphocytes, and high versus low dose IL-2 followed by pembrolizumab in patients with metastatic melanomaMerve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.
Pageof 29